Chemicals that modulate the microtubule cytoskeleton can indirectly influence the function of proteins like FAM110A, which are localized to the cytoplasm, microtubule organizing center, and spindle poles. Compounds such as paclitaxel and docetaxel act by stabilizing microtubules, which are critical components of the cellular framework and play a vital role during cell division. By promoting microtubule polymerization and their depolymerization, these agents can maintain the integrity of spindle poles, where FAM110A is localized, hence indirectly supporting its role in spindle assembly. Moreover, microtubule dynamics are essential for the proper segregation of chromosomes during mitosis, and stabilizers can enhance the accuracy of this process. Conversely, agents that disrupt microtubule polymerization, like nocodazole and colchicine, induce a spindle assembly checkpoint response, enhancing the role of FAM110A in checkpoint signaling pathways. These diverse effects on the microtubule network reflect the capacity of these chemicals to influence FAM110A's functional context within cells.
Microtubule-targeting agents such as vinblastine and vincristine, although traditionally considered as of microtubule formation, exert complex effects on the cell cycle and could activate pathways involving FAM110A, especially under conditions where microtubule dynamics are being manipulated. The subtle balance between microtubule polymerization and depolymerization is essential for the function of mitotic spindles and is a point of indirect modulation for FAM110A's activity. Kinesin spindle protein like monastrol and S-Trityl-L-cysteine target motor proteins that segregate chromosomes during cell division. By influencing spindle assembly, these could modulate FAM110A's role in maintaining spindle pole integrity. Similarly, BI-2536, a Polo-like kinase 1 (PLK1), despite its primary action, can indirectly impact spindle checkpoint functions and thus FAM110A activity by altering the phosphorylation status of proteins involved in mitosis. These chemicals represent a class of indirect activators that influence FAM110A by modulating the cellular scaffolding and machinery it associates with, rather than by binding to the protein directly. The use of these compounds to modulate the activity of FAM110A and similar proteins relies on a detailed understanding of the cell cycle, mitotic mechanisms, and the cytoskeletal architecture.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule stabilizer that promotes microtubule polymerization, enhancing spindle pole integrity where FAM110A localizes, thus indirectly supporting its function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule-disrupting agent that activates spindle assembly checkpoint; could indirectly enhance FAM110A's role in checkpoint responses. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Inhibits microtubule formation; while typically an inhibitor, it can activate spindle checkpoint pathways where FAM110A might be involved. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin, preventing microtubule polymerization, which could lead to activation of spindle assembly pathways involving FAM110A. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
Stabilizes microtubules, could enhance FAM110A spindle pole functions by maintaining microtubule integrity. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Inhibits microtubule assembly; may indirectly affect FAM110A by disrupting microtubule dynamics and spindle formation. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
A microtubule stabilizing drug; may influence FAM110A activity through enhancing microtubule dynamics. | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
Inhibits the mitotic kinesin Eg5, leading to monopolar spindle formation, potentially affecting FAM110A's function at the spindle poles. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
PLK1 inhibitor; although it's an inhibitor, it affects spindle assembly and could indirectly modulate the role of FAM110A in the spindle assembly checkpoint. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
A kinesin Eg5 inhibitor; affects spindle pole integrity and could influence FAM110A’s function in cell division. | ||||||